This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ken Carter, Jr.; Michael Halle; George Cherry; M. Bert Myers, MD

AMA Arch Surg. 1970;100(6):695-734.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

One of the most urgent needs in surgery today is a method of determining the viability of tissue known to be ischemic. All tissue can survive a varying period without blood supply, but at some point cellular death ensues. After this time, revascularization would be fruitless. 3-(4,5-Dimethylthiazol-2-yl) -2,5-diphenyl-2H-tetrazolium bromide (MTT) is a dye which is reduced by dehydrogenase enzymes found in living cells. As the dye is reduced, its color changes from yellow to dark blue. The rapidity with which the change occurs has been correlated with cell viability. Terasaki et al¹ first used this dye to evaluate cadaveric kidneys for transplantation purposes, reporting that it was a simple method of determining the viability of donor organs.

In the present experiment, canine ileum was subjected to various periods of total avascularity, and serial tests with the dye were performed. Our results showed a definite correlation between MTT dye times . . . [Full Text PDF of this Article]

Author Affiliations
New Orleans

From the Department of Surgery Louisiana State University School of Medicine (Dr. Myers, Mr. Carter, and Mr. Halle) and the Touro Research Institute (Dr. Myers and Mr. Cherry), New Orleans.

Footnotes
Accepted for publication Dec 23, 1969.

Reprint requests to 1400 Foucher St, New Orleans 70115 (Dr. Myers).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?